Why is Aurobindo Pharma falling/rising?

As of 08-Jul, Aurobindo Pharma Ltd. is experiencing a decline in its stock price, currently at 1,143.30, which reflects a decrease of 38.2 points or 3.23%. The stock has underperformed its sector by 2.3% today and has been on a downward trend for the last two days, accumulating a total decline of 3.88%. Additionally, the stock reached an intraday low of Rs 1130.15, indicating significant selling pressure. Over the past month, Aurobindo Pharma has seen a return of -1.46%, contrasting sharply with the Sensex's gain of 1.85%. Despite a relatively low Debt to Equity ratio and a fair valuation compared to peers, the stock's performance has been hindered by a falling investor participation, with delivery volume decreasing by 43.84% against the 5-day average.
In the broader market context, Aurobindo Pharma's short-term performance has been lackluster compared to the Sensex, which has shown a slight increase of 0.02% over the past week. The company's year-to-date return of -14.37% starkly contrasts with the Sensex's gain of 7.13%, indicating a significant underperformance. While the stock has high institutional holdings at 41.57%, suggesting confidence from larger investors, the overall market sentiment appears to be weighing heavily on Aurobindo Pharma's stock price, contributing to its recent decline.